Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Boostrix (GlaxoSmithKline).

¹ID Biomedical Corp of Quebec, Canada. tjones@idbiomedical.com

Idrugs : the Investigational Drugs Journal

|July 27, 2005

Summary

This summary is machine-generated.

GlaxoSmithKline has launched Boostrix, a new subunit vaccine. This vaccine provides booster immunization for adolescents and adults against diphtheria, tetanus, and pertussis infections.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The role of nasal IgA in children vaccinated with live attenuated influenza vaccine.

Vaccine·2012

Same author

Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials.

PloS one·2010

Same author

Vacc-4x, a therapeutic vaccine comprised of four engineered peptides for the potential treatment of HIV infection.

Current opinion in investigational drugs (London, England : 2000)·2010

Same author

GSK's novel split-virus adjuvanted vaccines for the prevention of the H5N1 strain of avian influenza infection.

Current opinion in molecular therapeutics·2009

Same author

IC-51, an injectable vaccine for the prevention of Japanese encephalitis virus infection.

Current opinion in molecular therapeutics·2009

Same author

IMVAMUNE, an attenuated modified vaccinia Ankara virus vaccine for smallpox infection.

Current opinion in molecular therapeutics·2008

Area of Science:

Immunology
Vaccinology

Background:

Diphtheria, tetanus, and pertussis (DTPa) pose significant public health risks.
Booster immunizations are crucial for maintaining long-term immunity.

Purpose of the Study:

To introduce Boostrix, a subunit vaccine developed by GlaxoSmithKline.
To highlight its role as a booster immunization for adolescents and adults.

Main Methods:

Development and launch of a subunit vaccine formulation.
Targeting adolescents and adults for booster immunization.

Main Results:

Boostrix is now available for DTPa booster immunization.
Provides protection against diphtheria, tetanus, and pertussis.

Conclusions:

Boostrix offers a new option for DTPa booster immunization in adolescents and adults.
Aims to enhance population immunity against these infectious diseases.